Literature DB >> 1757565

Emergence of homogeneously methicillin-resistant Staphylococcus aureus.

J Fung-Tomc1, E Huczko, E Gradelski, K Denbleyker, D P Bonner, R E Kessler.   

Abstract

Forty-seven clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA), collected between 1986 and 1990 from 29 institutions, were analyzed for susceptibility to various antibiotics. Twenty-six strains were homogeneously methicillin resistant (i.e., greater than or equal to 10% of the cells in these strains were able to grow on Mueller-Hinton agar containing 50 micrograms of methicillin per ml). The MICs of gentamicin, clindamycin, trimethoprimsulfamethoxazole, methicillin, and imipenem for homogeneous MRSA strains were higher than those for heterogeneously resistant strains. Both types of strains were, for the most part, susceptible to vancomycin and trimethoprim-sulfamethoxazole. Ciprofloxacin-resistant MRSA strains were not isolated prior to 1988 but made up 40% of the post-1987 strains. The level of methicillin resistance correlated well with the imipenem MIC, suggesting that susceptibility to imipenem may serve as a marker to identify and monitor the prevalence of homogeneous MRSA strains.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1757565      PMCID: PMC270453          DOI: 10.1128/jcm.29.12.2880-2883.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

Review 1.  Methicillin-resistant Staphylococcus aureus.

Authors:  W Brumfitt; J Hamilton-Miller
Journal:  N Engl J Med       Date:  1989-05-04       Impact factor: 91.245

Review 2.  Methicillin-resistant staphylococci: detection methods and treatment of infections.

Authors:  C J Hackbarth; H F Chambers
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

3.  Methicillin-resistant Staphylococcus aureus in Veterans Administration Medical Centers.

Authors:  L C Preheim; D Rimland; M J Bittner
Journal:  Infect Control       Date:  1987-05

4.  Role of beta-lactamase in expression of resistance by methicillin-resistant Staphylococcus aureus.

Authors:  J M Boyce; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

5.  Expression and inducibility in Staphylococcus aureus of the mecA gene, which encodes a methicillin-resistant S. aureus-specific penicillin-binding protein.

Authors:  K Ubukata; R Nonoguchi; M Matsuhashi; M Konno
Journal:  J Bacteriol       Date:  1989-05       Impact factor: 3.490

6.  Subinhibitory concentrations of imipenem induce increased resistance to methicillin and imipenem in vitro in methicillin-resistant Staphylococcus aureus.

Authors:  B A Forbes; K D McClatchey; D R Schaberg
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

7.  Occurrence of a beta-lactam-inducible penicillin-binding protein in methicillin-resistant staphylococci.

Authors:  K Ubukata; N Yamashita; M Konno
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

Review 8.  Gram-positive bacteria: spread and antimicrobial resistance in university and community hospitals in the USA.

Authors:  J E McGowan
Journal:  J Antimicrob Chemother       Date:  1988-04       Impact factor: 5.790

9.  Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus.

Authors:  B J Hartman; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

10.  Phenotypic suppression of methicillin resistance in Staphylococcus aureus by mutant noninducible penicillinase plasmids.

Authors:  S Cohen; C J Gibson; H M Sweeney
Journal:  J Bacteriol       Date:  1972-11       Impact factor: 3.490

View more
  1 in total

1.  Evaluation of Rapid ATB Staph for 5-hour antimicrobial susceptibility testing of Staphylococcus aureus. Groupement pour le Dépistage, L'Etude et la Prévention des Infections Hospitalières-Groep ter Opsporing, Studie en Preventie van Infecties in de Ziekenhuizen.

Authors:  M J Struelens; C Nonhoff; P van der Auwera; R Mertens; E Serruys
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.